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Endovascular Management of Aortoiliac Occlusive Disease
Nitin Verma, MD, Amit Nanavati, MD, Bryan Kluck, DO
Background: 
Patients with aortoiliac occlusive disease (AIOD) may be asymptomatic or may have intermittent 
claudication or critical limb ischemia. 
Treatment options for AIOD include management of risk factors, endovascular intervention, and/or surgical 
revascularization.
Endovascular therapy is the treatment of choice for type A and the preferred treatment for type B lesions. 
In selective patients, this type of treatment can be applied in type C and even type D lesions. Ipsilateral 
femoral, contralateral femoral, and brachial approach and both the intraluminal and subintimal space can 
be used for successful recanalization.
The choice of stent type depends on lesion morphology and location but otherwise there is insufficient 
evidence to support the use of a particular stent design.
Case Report: 
67-year-old white female with CAD post coronary artery bypass grafting, complete heart block s/p 
pacemaker with severe peripheral vascular disease was diagnosed to have bilateral aortoiliac disease 
with aorto-ilio-bifemoral angiography confirming in-stent restenosis of bilateral iliac artery stents. A 
successful covered stent was placed and balloon angioplasty procedure was performed on the 85% lesion 
in the left common iliac artery. Following intervention there was an excellent angiographic appearance 
with a 0% residual stenosis. This was a bifurcation lesion. There was no evidence of the transient no-
reflow phenomenon. This was followed by another covered stent and balloon angioplasty procedure was 
performed on the 80% lesion in the right common iliac artery.
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Discussion: 
Traditionally, TASC C/D lesions are referred for surgical repair. Between 1997 
and 2007, 118 aortofemoral bypass (AFB) and 174 aortic stent (AS) procedures 
were performed in 161men (55.1%) and 131 women at a single center.
No difference between AFB and AS groups with respect to 30-day mortality 
(0.8% and 1.1%, p < 0.64), myocardial infarction (1.7% and 1.1%, p < 0.53), 
cerebrovascular accident (0.0% and 1.1%, p < 0.35), or renal failure requiring 
hemodialysis (3.4% and 1.2%, p < 0.19). 
AFB was associated with increased surgical complication rates including the 
need for emergency surgery (6.8% and 1.7%, p < 0.029), infection/sepsis 
(16.1% and 2.3%, p < 0.001), transfusion (16.1% and 5.7%, p < 0.004), and 
lymph leak (8.5% and 0.6%, p < 0.001).
Access site as well as distal embolization are the primary complications (3.5% 
vs. 8-13% OR rate)
Freedom from mortality, revision, amputation similar.
Conclusions: 
The high prevalence of AIOD and potential for severe lifestyle-limiting claudication and/or 
tissue loss necessitates appropriate evaluation and management of this disease.
With a combination of medical management of modifiable risk factors, accurate noninvasive 
and/or invasive diagnostic evaluation and endovascular and/or surgical revascularization when 


































































































































































































aortic occlusion with 
distal reconstitution prior 
to the aortoiliac junction.
An angled glidewire was 
advanced into the left 
common iliac artery and 
percutaneous transluminal 
angioplasty (PTA) of 
the distal aorta was 
performed.
Right femoral artery access 
was obtained and a wire 
passed through the flap. 
This wire was ultimately 
exteriorized through the left 
brachial sheath.
A distinct stenosis is now 
seen in the left common iliac 
artery. Thus, simultaneous 
self expanding bare metal 
stents were deployed in the 
distal aorta into each the left 
and right common iliac. A 
crossing configuration was 
used, effectively recreating the 
aortoiliac bifurcation.
Final result demonstrating brisk flow with patent stents 
and no focal obstructions.
Female gender, prior occlusion-univariate risk factors
Geometric mismatch may affect patency rates.
